Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Colmegna

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
ACR Open Rheumatology|July 1, 2021
Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory StudyCarol A Hitchon, Girsh M Mody, Candace H Feldman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Clinical Rheumatology|October 8, 2020
A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritisValeria Valerio, Maria Celia Bazan, Mianbo Wang, et al.
Plos One|May 17, 2019
Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosisChen-Fang Chung, Thomas Kitzler, Nadezda Kachurina, et al.
ACR Open Rheumatology|March 29, 2022
Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis CohortViviane Ta, Orit Schieir, Marie-France Valois, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
The Journal of Rheumatology|January 15, 2023
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory DiseasesGlen S Hazlewood, Ines Colmegna, Carol Hitchon, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
ACR Open Rheumatology|July 1, 2021
Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory StudyCarol A Hitchon, Girsh M Mody, Candace H Feldman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of LifeNancy Maltez, Mathieu Puyade, Mianbo Wang, et al.
Clinical Rheumatology|October 8, 2020
A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritisValeria Valerio, Maria Celia Bazan, Mianbo Wang, et al.
Plos One|May 17, 2019
Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosisChen-Fang Chung, Thomas Kitzler, Nadezda Kachurina, et al.
ACR Open Rheumatology|March 29, 2022
Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis CohortViviane Ta, Orit Schieir, Marie-France Valois, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
The Journal of Rheumatology|January 15, 2023
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory DiseasesGlen S Hazlewood, Ines Colmegna, Carol Hitchon, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Pageof 5